Women With High Risk Should Have Mri Of The Breast

Magnetic resonance imaging (MRI) of the breast is a much more sensitive test for detecting breast tumors when compared to mammogram. A recent study has observed that women who have genetic mutation and high risk of developing breast cancer should receive MRI of the breast rather than mammogram as the screening test for breast cancer.

Women who inherit BRCA1 and BRCA2 genetic mutations have about 60 to 80 percent lifetime risk of developing breast cancer. Magnetic resonance imaging (MRI) is the best screening test for those women who have BRCA mutation. MRI is expensive and costs 10 times more than mammography but is capable of detecting small tumors, which may be missed by mammogram giving a chance to treat such tumors earlier. However the high sensitivity of MRI causes significant false positive results, by showing a number of non-malignant breast abnormalities.

Scientists used computer models that set a threshold of $100,000 spent for each year of life gained and demonstrated that use of MRI in high-risk women is cost effective for young women (35 to 54 years) who carry BRCA1 and BRCA2 mutations.

Scientists Stanford University School of Medicine who conducted this study expressed the hope that, declining cost of MRI would make it cost effective for even wider group of women in future.